Target intelligence / Profile preview

RBM15 antisense RNA 1 (RBM15-AS1)

Target
RBM15-AS1
Molecular classification
Long non-coding RNA (lncRNA), Antisense RNA, Other
01

Overview

RBM15 antisense RNA 1 (RBM15-AS1) is a long non-coding RNA transcribed antisense from the RBM15 gene locus on human chromosome 1. RBM15-AS1 enhances RBM15 protein translation via overlap with the RBM15 5′UTR, functioning in a CAP-dependent manner. Its upregulation promotes terminal differentiation of megakaryocytes, while its knockdown attenuates this process. RBM15-AS1 and its sense counterpart, RBM15, are both transcriptionally regulated by RUNX1 (a key hematopoietic transcription factor) and are repressed by the RUNX1-ETO fusion protein, common in certain leukemias. While RBM15-AS1 is primarily nuclear, its cytoplasmic levels increase during cellular differentiation signals. As a lncRNA, it provides a layer of post-transcriptional regulation fine-tuning RBM15 protein output, which is critical for proper hematopoietic cell differentiation and may be linked to the pathogenesis of specific leukemias[1][2].

Other names
AS-RBM15RBM15-AS1AS_RBM15
02

Biological functions

Regulation of protein translation (RBM15)Regulatory role in megakaryocyte differentiationFine-tuning gene dosageOther
03

Disease associations

Cancer (Leukemias, particularly acute megakaryocytic leukemia and potentially other subtypes through regulation of hematopoiesis and leukemogenesis)Other

Beyond the preview

Go deeper on RBM15 antisense RNA 1 (RBM15-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RBM15 antisense RNA 1 (RBM15-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call